{"transactions":[{"id":2394735,"issuer":{"id":87127,"kind":"organization","name":"CareMax, Inc.","symbol":"CMAX"},"owners":[{"id":130407,"kind":"organization","name":"DFHTA Sponsor LLC","position":1,"cik":"0001817569","reported_name":"DFHTA Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":2,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Private Placement Warrants","published_at":"2022-02-15T18:23:43.000Z","date":"2022-02-11","kind":"other","acquired":false,"shares":2916667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 11, 2022, DFHTA Sponsor LLC (the \"Sponsor\") distributed 3,768,750 shares of the Issuer's Class A common stock and 2,916,667 Private Placement Warrants to its members, on a pro rata basis for no consideration, in connection with the dissolution of the Sponsor."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor was the record holder of the securities reported herein. Mr. Atinsky is a manager of the Sponsor and shared voting and investment discretion with respect to the common stock held of record by the Sponsor. Mr. Atinsky disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":11.5,"exercise_date":"2021-07-21","expiration_date":"2026-06-08","underlying":"Class A common stock","underlying_shares":2916667},"source":{"system":"sec-edgar","filing":"0001193805-22-000346","document":"e621361_4-dfhta.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817569/000119380522000346/e621361_4-dfhta.xml","form_type":"4"}},{"id":2394734,"issuer":{"id":87127,"kind":"organization","name":"CareMax, Inc.","symbol":"CMAX"},"owners":[{"id":130407,"kind":"organization","name":"DFHTA Sponsor LLC","position":1,"cik":"0001817569","reported_name":"DFHTA Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":2,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A common stock","published_at":"2022-02-15T18:23:43.000Z","date":"2022-02-11","kind":"other","acquired":false,"shares":3768750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 11, 2022, DFHTA Sponsor LLC (the \"Sponsor\") distributed 3,768,750 shares of the Issuer's Class A common stock and 2,916,667 Private Placement Warrants to its members, on a pro rata basis for no consideration, in connection with the dissolution of the Sponsor."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Sponsor was the record holder of the securities reported herein. Mr. Atinsky is a manager of the Sponsor and shared voting and investment discretion with respect to the common stock held of record by the Sponsor. Mr. Atinsky disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-22-000346","document":"e621361_4-dfhta.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817569/000119380522000346/e621361_4-dfhta.xml","form_type":"4"}},{"id":2511286,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":133488,"kind":"organization","name":"DFP Sponsor LLC","position":1,"cik":"0001806360","reported_name":"DFP Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":113177,"kind":"person","name":"HOCHBERG STEVEN","position":2,"cik":"0001034123","reported_name":"HOCHBERG STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":3,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Private Placement Warrants","published_at":"2021-11-16T21:36:55.000Z","date":"2021-11-12","kind":"other","acquired":true,"shares":3177543,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The Sponsor acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on March 13, 2020. As a result of the closing of the Issuer's initial business combination, the Private Placement Warrants will become exercisable as of the date that is 30 days after the closing of the Issuer's initial business combination (i.e., November 12, 2021). The Private Placement Warrants will expire on November 12, 2026 or earlier upon redemption or liquidation. Prior to the closing of the Issuer's initial business combination, the Sponsor elected to be governed by a Maximum Percentage (as defined in the Private Placement Warrants) of 4.9%."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed by DFP Sponsor, LLC (the \"Sponsor\"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":3177543,"derivative":{"exercise_price":11.5,"exercise_date":"2021-12-12","expiration_date":"2026-11-12","underlying":"Class A Common Stock","underlying_shares":3177543},"source":{"system":"sec-edgar","filing":"0001193805-21-001591","document":"e621087_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1034123/000119380521001591/e621087_4-dfp.xml","form_type":"4"}},{"id":2511285,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":133488,"kind":"organization","name":"DFP Sponsor LLC","position":1,"cik":"0001806360","reported_name":"DFP Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":113177,"kind":"person","name":"HOCHBERG STEVEN","position":2,"cik":"0001034123","reported_name":"HOCHBERG STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":3,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class B Common Stock","published_at":"2021-11-16T21:36:55.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":40,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed by DFP Sponsor, LLC (the \"Sponsor\"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40},"source":{"system":"sec-edgar","filing":"0001193805-21-001591","document":"e621087_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1034123/000119380521001591/e621087_4-dfp.xml","form_type":"4"}},{"id":2511284,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":133488,"kind":"organization","name":"DFP Sponsor LLC","position":1,"cik":"0001806360","reported_name":"DFP Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":113177,"kind":"person","name":"HOCHBERG STEVEN","position":2,"cik":"0001034123","reported_name":"HOCHBERG STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":3,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class B Common Stock","published_at":"2021-11-16T21:36:55.000Z","date":"2021-11-12","kind":"other","acquired":false,"shares":707960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F5","text":"In connection with, and immediately prior to, the closing of the Issuer's initial business combination, pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, the Sponsor forfeited 707,960 shares of Class B Common Stock for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares of Class B Common Stock were convertible into shares of the Issuer's Class A Common Stock as described under the heading \"Description of Securities\" in the Issuer's Registration Statement on Form S-1 (File No. 333-236578) and had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed by DFP Sponsor, LLC (the \"Sponsor\"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":40,"derivative":{"underlying":"Class A Common Stock","underlying_shares":707960},"source":{"system":"sec-edgar","filing":"0001193805-21-001591","document":"e621087_4-dfp.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1034123/000119380521001591/e621087_4-dfp.xml","form_type":"4"}},{"id":2511283,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":133488,"kind":"organization","name":"DFP Sponsor LLC","position":1,"cik":"0001806360","reported_name":"DFP Sponsor LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":113177,"kind":"person","name":"HOCHBERG STEVEN","position":2,"cik":"0001034123","reported_name":"HOCHBERG STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":3,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Members of 10% Group"}}],"security":"Class A Common Stock","published_at":"2021-11-16T21:36:55.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":40,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Upon the closing of the Issuer's initial business combination, each share of Class B Common Stock converted (automatically in accordance with its terms) into one share of Class A Common Stock for no consideration."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed by DFP Sponsor, LLC (the \"Sponsor\"), as well as Steven Hochberg and Lawrence Atinsky, each of whom is a manager of the Sponsor."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Sponsor is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each or Steven Hochberg and Lawrence Atinsky disclaims beneficial ownership of any such securities, except to the extent of his indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that Mr. Hochberg or Mr. Atinsky is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":40,"source":{"system":"sec-edgar","filing":"0001193805-21-001591","document":"e621087_4-dfp.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1034123/000119380521001591/e621087_4-dfp.xml","form_type":"4"}},{"id":2674182,"issuer":{"id":87127,"kind":"organization","name":"CareMax, Inc.","symbol":"CMAX"},"owners":[{"id":130407,"kind":"organization","name":"DFHTA Sponsor LLC","position":1,"cik":"0001817569","reported_name":"DFHTA Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":2,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Private Placement Warrants","published_at":"2021-06-10T17:45:02.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":2916667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"DFHTA Sponsor LLC acquired the Private Placement Warrants from the Issuer in connection with the Issuer's initial public offering on July 21, 2020. As a result of the closing of the Business Combination, the Private Placement Warrants will become exercisable as of the date that is 12 months after the closing of the Issuer's initial public offering (i.e., July 21, 2021). The Private Placement Warrants will expire on June 8, 2026 or earlier upon redemption or liquidation."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"DFHTA Sponsor LLC is the record holder of the securities reported herein. Mr. Atinsky is a manager of DFHTA Sponsor LLC and shares voting and investment discretion with respect to the common stock held of record by DFHTA Sponsor LLC. Mr. Atinsky disclaims any beneficial ownership of the securities held by DFHTA Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Steven Hochberg, a manager of DFHTA Sponsor LLC previously served as chief executive officer of the Issuer and, until immediately following consummation of the Business Combination, a member of the Issuer's board of directors."}],"balance_after":2916667,"derivative":{"exercise_price":11.5,"exercise_date":"2021-07-21","expiration_date":"2026-06-08","underlying":"Class A common stock","underlying_shares":2916667},"source":{"system":"sec-edgar","filing":"0001193805-21-000838","document":"e620696_4-dfhta.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817569/000119380521000838/e620696_4-dfhta.xml","form_type":"4"}},{"id":2674181,"issuer":{"id":87127,"kind":"organization","name":"CareMax, Inc.","symbol":"CMAX"},"owners":[{"id":130407,"kind":"organization","name":"DFHTA Sponsor LLC","position":1,"cik":"0001817569","reported_name":"DFHTA Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":2,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B common stock","published_at":"2021-06-10T17:45:02.000Z","date":"2021-06-08","kind":"exercise","acquired":false,"shares":3368750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock."},{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"DFHTA Sponsor LLC is the record holder of the securities reported herein. Mr. Atinsky is a manager of DFHTA Sponsor LLC and shares voting and investment discretion with respect to the common stock held of record by DFHTA Sponsor LLC. Mr. Atinsky disclaims any beneficial ownership of the securities held by DFHTA Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Steven Hochberg, a manager of DFHTA Sponsor LLC previously served as chief executive officer of the Issuer and, until immediately following consummation of the Business Combination, a member of the Issuer's board of directors."}],"balance_after":0,"derivative":{"underlying":"Class A common stock","underlying_shares":3368750},"source":{"system":"sec-edgar","filing":"0001193805-21-000838","document":"e620696_4-dfhta.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817569/000119380521000838/e620696_4-dfhta.xml","form_type":"4"}},{"id":2674180,"issuer":{"id":87127,"kind":"organization","name":"CareMax, Inc.","symbol":"CMAX"},"owners":[{"id":130407,"kind":"organization","name":"DFHTA Sponsor LLC","position":1,"cik":"0001817569","reported_name":"DFHTA Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":2,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A common stock","published_at":"2021-06-10T17:45:02.000Z","date":"2021-06-08","kind":"exercise","acquired":true,"shares":3368750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the closing of the Business Combination, each share of the Issuer's Class B common stock automatically converted into one share of the Issuer's Class A common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"DFHTA Sponsor LLC is the record holder of the securities reported herein. Mr. Atinsky is a manager of DFHTA Sponsor LLC and shares voting and investment discretion with respect to the common stock held of record by DFHTA Sponsor LLC. Mr. Atinsky disclaims any beneficial ownership of the securities held by DFHTA Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Steven Hochberg, a manager of DFHTA Sponsor LLC previously served as chief executive officer of the Issuer and, until immediately following consummation of the Business Combination, a member of the Issuer's board of directors."}],"balance_after":3768750,"source":{"system":"sec-edgar","filing":"0001193805-21-000838","document":"e620696_4-dfhta.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817569/000119380521000838/e620696_4-dfhta.xml","form_type":"4"}},{"id":2674179,"issuer":{"id":87127,"kind":"organization","name":"CareMax, Inc.","symbol":"CMAX"},"owners":[{"id":130407,"kind":"organization","name":"DFHTA Sponsor LLC","position":1,"cik":"0001817569","reported_name":"DFHTA Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":2,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A common stock","published_at":"2021-06-10T17:45:02.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":400000,"price":10,"value":4000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 8, 2021, immediately prior to, and conditioned upon the consummation of, CareMax, Inc.'s (formerly known as Deerfield Healthcare Technology Acquisitions Corp.) (the \"Issuer\") business combination with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC (the \"Business Combination\"), DFHTA Sponsor LLC acquired from the Issuer 400,000 shares of Class A common stock of the Issuer."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"DFHTA Sponsor LLC is the record holder of the securities reported herein. Mr. Atinsky is a manager of DFHTA Sponsor LLC and shares voting and investment discretion with respect to the common stock held of record by DFHTA Sponsor LLC. Mr. Atinsky disclaims any beneficial ownership of the securities held by DFHTA Sponsor LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly. Steven Hochberg, a manager of DFHTA Sponsor LLC previously served as chief executive officer of the Issuer and, until immediately following consummation of the Business Combination, a member of the Issuer's board of directors."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001193805-21-000838","document":"e620696_4-dfhta.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817569/000119380521000838/e620696_4-dfhta.xml","form_type":"4"}},{"id":3710141,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":1,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-01-03T21:06:16.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person, a partner at Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Reporting Person, a partner at Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Person, a partner at Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities."}],"balance_after":62500,"derivative":{"exercise_price":0.4,"exercise_date":"2018-12-31","expiration_date":"2025-12-31","underlying":"COMMON STOCK","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001091596-19-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000109159619000006/primary_doc.xml","form_type":"4"}},{"id":3846478,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":1,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2018-08-13T20:10:46.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":109375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1) The Reporting Person, a partner at Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"1) The Reporting Person, a partner at Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"1) The Reporting Person, a partner at Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities."}],"balance_after":109375,"derivative":{"exercise_price":0.4,"exercise_date":"2018-08-09","expiration_date":"2025-08-09","underlying":"COMMON STOCK","underlying_shares":109375},"source":{"system":"sec-edgar","filing":"0001605411-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000160541118000004/primary_doc.xml","form_type":"4"}},{"id":4493253,"issuer":{"id":7149,"kind":"organization","name":"Nuo Therapeutics, Inc.","symbol":"AURX"},"owners":[{"id":130408,"kind":"person","name":"Atinsky Lawrence","position":1,"cik":"0001674477","reported_name":"Atinsky Lawrence","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2017-01-12T01:18:13.000Z","date":"2017-01-09","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The grant of these options was approved by the issuer's board of directors on July 1, 2016, subject to stockholder approval of the 2016 Omnibus Incentive Compensation Plan under which the options were granted. Stockholder approval was obtained by means of a written consent and the issuer filed a related Information Statement on Schedule 14C with the SEC on November 25, 2016. The stockholder approval became effective on January 9, 2017."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Of these options, 15,000 vested immediately, and 25,000 vested on 1/1/17."}],"balance_after":40000,"derivative":{"exercise_price":1,"expiration_date":"2026-07-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001144204-17-001880","document":"v456638_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1091596/000114420417001880/v456638_4.xml","form_type":"4"}}]}